Category: Brain Tumor

Home / Established Year

Tovorafenib has been granted accelerated approval by the FDA for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma

Tovorafenib has been granted accelerated approval by the FDA for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma

April 2024: The Food and Drug Administration (FDA) granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.). This approval is specifically for patients aged 6 months and older who have relapsed or ref..

Eflornithine is approved by USFDA for adult and pediatric patients with high-risk neuroblastoma

Eflornithine is approved by USFDA for adult and pediatric patients with high-risk neuroblastoma

The FDA approved eflornithine (IWILFIN, USWM, LLC) on December 13, 2023, to lower the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who had a partial response to previous multiagent, multimodality th..

Glioblastoma CAR T Cell therapy clinical trials
, , ,

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

March 2023: Study Type : Interventional (Clinical Trial)Estimated Enrollment : 30 participantsAllocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: a "3+3" design is used to determine Maximum..

CAR T-Cell therapy for childhood brain tumor

Dec 2021: CAR T-Cell therapy is currently approved for some forms of leukemia, lymphoma, and multiple myeloma. Researchers have now also developed the corresponding GD2 CAR T-cell therapy for the treatment of neuroblastoma, i.e., ..

Significant discovery: the aggressiveness of brain tumors is related to the enhancement of gene activity

Scientists at the University of California, San Francisco have discovered a common genetic driver of aggressive meningioma, which can help clinicians detect this dangerous cancer earlier and find new treatments for these difficult..

Mobile phone radiation and brain tumors

The California Department of Public Health issued guidelines on cell phone radiation and how to reduce exposure.According to the CBS report, although there is no conclusive medical evidence, some studies have shown that mobile pho..

Brain metastasis in breast cancer

Breast cancer With the advancement of breast cancer diagnosis and treatment, the survival time of breast cancer patients has prolonged significantly, but the incidence of breast cancer brain metastases (BCBM) has gradually increa..

,

What is better for medulloblastoma – Traditional radiotherapy or proton therapy?

Myeloblastoma is one of the most common childhood tumors. Among children under 10 years of age, the incidence rate is about 20% to 30% of all tumors. The peak age of onset is 5 years, and men are slightly more than women. The tum..

, , ,

Magic electric field for treatment of brain tumor

There is recent developments on magic electric field for treatment of brain tumor.Glioblastoma is a deadly disease called the "terminator" because this tumor grows very quickly and can affect anyone of any age, with a poor prognos..

Breakthrough In Childhood Brain Tumor Drugs
,

Breakthrough in childhood brain tumor drugs

There is a big breakthrough in childhood brain tumor drug development. Children's brain tumors are a more common malignant disease in children. Recent research has found that a new cocktail drug can treat common childhood brain tu..

Newer
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy